{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:07:53Z","timestamp":1788926873668,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Facepe","doi-asserted-by":"crossref","award":["APQ-0498-4.03\/19"],"award-info":[{"award-number":["APQ-0498-4.03\/19"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["404264\/2016-6"],"award-info":[{"award-number":["404264\/2016-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s43440-021-00221-7","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T17:27:23Z","timestamp":1613669243000},"page":"907-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors"],"prefix":"10.1007","volume":"73","author":[{"given":"\u00cdris T. T.","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana O. S.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirelly D. S.","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinara M. V.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iranildo J.","family":"da Cruz-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha G.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo R. M.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane M. L.","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamerson F.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C. A.","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"221_CR1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","volume":"24","author":"YT Yeung","year":"2018","unstructured":"Yeung YT, Aziz F, Guerrero-Castilla A, Arg\u00fcelles S. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24:1449\u201384. https:\/\/doi.org\/10.2174\/1381612824666180327165604.","journal-title":"Curr Pharm Des"},{"key":"221_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejmech.2017.09.003","volume":"140","author":"P Singh","year":"2017","unstructured":"Singh P, Kaur S, Sharma A, Kaur G, Bhatti R. TNF-\u03b1 and IL-6 inhibitors: Conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents. Eur J Med Chem. 2017;140:92\u2013103. https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.003.","journal-title":"Eur J Med Chem"},{"key":"221_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","volume":"25","author":"LM Sedger","year":"2014","unstructured":"Sedger LM, McDermott MF. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants\u2014past, present and future. Cytokine Growth Factor Rev. 2014;25:453\u201372. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.07.016.","journal-title":"Cytokine Growth Factor Rev"},{"key":"221_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/S0482-50042010000400008","volume":"50","author":"WM Cruvinel","year":"2010","unstructured":"Cruvinel WM, Mesquita-J\u00fanior D, Ara\u00fajo JAP, Catelan TTT, de Souza AWS, da Silva NP, et al. Immune system\u2014part I Fundamentals of innate immunity with emphasis on molecular and cellular mechanisms of inflammatory response. Rev Bras Reumatol. 2010;50:434\u201361. https:\/\/doi.org\/10.1590\/S0482-50042010000400008.","journal-title":"Rev Bras Reumatol"},{"key":"221_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ejmech.2016.04.028","volume":"18","author":"DP Gouvea","year":"2016","unstructured":"Gouvea DP, Vasconcellos FA, Berwaldt GA, Seixas-Neto ACP, Fischer G, Sakata RP, et al. 2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: synthesis, antiinflammatory in vivo, cytotoxicity in vitro and molecular docking studies. Eur J Med Chem. 2016;18:259\u201365. https:\/\/doi.org\/10.1016\/j.ejmech.2016.04.028.","journal-title":"Eur J Med Chem"},{"key":"221_CR6","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1136\/heartjnl-2018-313313","volume":"104","author":"MD Buono","year":"2018","unstructured":"Buono MD, Abbate A, Toldo S. Interplay of inflammation, oxidative stress and cardiovascular disease in rheumatoid arthritis. Heart. 2018;104:1991\u20132. https:\/\/doi.org\/10.1136\/heartjnl-2018-313313.","journal-title":"Heart"},{"key":"221_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioorg.2015.11.001","volume":"64","author":"KRA Abdellatif","year":"2016","unstructured":"Abdellatif KRA, Abdelgawad MA, Elshemy HAH, Alsayed SSR. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem. 2016;64:1\u201312. https:\/\/doi.org\/10.1016\/j.bioorg.2015.11.001.","journal-title":"Bioorg Chem"},{"key":"221_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejmech.2016.03.011","volume":"115","author":"AAM Abdel-Aziz","year":"2016","unstructured":"Abdel-Aziz AAM, El-Azab AS, Abou-Zeid LA, ElTahir KEH, Abdel-Aziz NI, Ayyad RR, et al. Synthesis, anti-inflammatory, analgesic and COX-1\/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: molecular docking studies. Eur J Med Chem. 2016;115:121\u201331. https:\/\/doi.org\/10.1016\/j.ejmech.2016.03.011.","journal-title":"Eur J Med Chem"},{"key":"221_CR9","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.bmcl.2011.01.057","volume":"21","author":"BJ Al-Hourani","year":"2011","unstructured":"Al-Hourani BJ, Sharma SK, Mane JY, Tuszynski J, Baracos V, Kniess T, et al. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles a novel selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett. 2011;21:1823\u20136. https:\/\/doi.org\/10.1016\/j.bmcl.2011.01.057.","journal-title":"Bioorg Med Chem Lett"},{"key":"221_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/mi.6.4.6","volume":"6","author":"R Rajakariar","year":"2006","unstructured":"Rajakariar R, Yaqoob MM, Gilroy DW. COX-2 in Inflammation and Resolution. Mol Interv. 2006;6:199\u2013207. https:\/\/doi.org\/10.1124\/mi.6.4.6.","journal-title":"Mol Interv"},{"key":"221_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","volume":"150","author":"S Dadashpour","year":"2018","unstructured":"Dadashpour S, Emami S. Indole in the target-based design of anticancer agents: a versatile scaffold with diverse mechanisms. Eur J Med Chem. 2018;150:9\u201329. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.065.","journal-title":"Eur J Med Chem"},{"key":"221_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejmech.2019.07.004","volume":"180","author":"Y Huang","year":"2019","unstructured":"Huang Y, Zhang B, Li J, Liu H, Zhang Y, Yang Z, et al. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX. Eur J Med Chem. 2019;180:41\u201350. https:\/\/doi.org\/10.1016\/j.ejmech.2019.07.004.","journal-title":"Eur J Med Chem"},{"key":"221_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.biopha.2016.03.047","volume":"80","author":"JF Oliveira","year":"2016","unstructured":"Oliveira JF, Nonato FR, Zafred RRT, Leite NMS, Ruiz ALTG, de Carvalho JE, et al. Evaluation of anti-inflammatory effect of derivative (E)-N-(4-bromophenyl)-2-(thiophen-2-ylmethylene)-thiosemicarbazone. Biomed Pharmacother. 2016;80:388\u201392. https:\/\/doi.org\/10.1016\/j.biopha.2016.03.047.","journal-title":"Biomed Pharmacother"},{"key":"221_CR14","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1016\/j.bmc.2018.07.024","volume":"26","author":"ADTO Moraes","year":"2018","unstructured":"Moraes ADTO, de Miranda MDS, Jacob ITT, Amorim CAC, de Moura RO, da Silva SAS, et al. Synthesis, in vitro and in vivo biological evaluation, COX-1\/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives. Bioorg Med Chem. 2018;26:5388\u201396. https:\/\/doi.org\/10.1016\/j.bmc.2018.07.024.","journal-title":"Bioorg Med Chem"},{"key":"221_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejmech.2015.09.036","volume":"104","author":"JF Oliveira","year":"2015","unstructured":"Oliveira JF, da Silva AL, Vendramini-Costa DB, Amorim CAC, Campos JF, Ribeiro AG, et al. Synthesis of thiophene-thiosemicarbazone derivatives and evaluation of their in vitro and in vivo antitumor activities. Eur J Med Chem. 2015;104:148\u201356. https:\/\/doi.org\/10.1016\/j.ejmech.2015.09.036.","journal-title":"Eur J Med Chem"},{"key":"221_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejmech.2017.05.023","volume":"136","author":"JF Oliveira","year":"2017","unstructured":"Oliveira JF, Lima TS, Vendramini-Costa DB, Pedrosa SCBL, Lafayette EA, da Silva RMF, et al. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay. Eur J Med Chem. 2017;136:305\u201314. https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.023.","journal-title":"Eur J Med Chem"},{"key":"221_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.poly.2017.05.003","volume":"132","author":"AM Plut\u00edn","year":"2017","unstructured":"Plut\u00edn AM, Alvarez A, Mocelo R, Ramos R, Castellano EE, Silva MM, et al. Palladium(II)\/N, N-disubstituted-N\u2032-acylthioureas complexes as anti-Mycobacterium tuberculosis and anti-Trypanosoma cruzi agents. Polyhedron. 2017;132:70\u20137. https:\/\/doi.org\/10.1016\/j.poly.2017.05.003.","journal-title":"Polyhedron"},{"key":"221_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt470","volume":"5","author":"DN Silva","year":"2014","unstructured":"Silva DN, Souza BSF, Azevedo CM, Vasconcelos JF, Carvalho RH, Soares MBP, et al. Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy. Stem Cell Res Ther. 2014;5:1\u201310. https:\/\/doi.org\/10.1186\/scrt470.","journal-title":"Stem Cell Res Ther"},{"key":"221_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-364-6","volume-title":"Cyclooxygenases: Methods and Protocols, Methods in Molecular Biology","author":"SS Ayoub","year":"2010","unstructured":"Ayoub SS, Flower RJ, Seed M. Cyclooxygenases: Methods and Protocols, Methods in Molecular Biology. Hoboken: Humana Press; 2010."},{"key":"221_CR20","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","volume":"141","author":"AH Ding","year":"1988","unstructured":"Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988;141:2407\u201312.","journal-title":"J Immunol."},{"key":"221_CR21","unstructured":"OECD (2002) Guidance Document on acute oral toxicity testing"},{"key":"221_CR22","unstructured":"OECD (2000) Guidance document on the recognition, assessment and use of clinical signs as humane endpoints for experimental animals used in safety evaluation"},{"key":"221_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3181\/00379727-111-27849","volume":"111","author":"CA Winter","year":"1962","unstructured":"Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Exper Bio Med. 1962;111:544\u20137. https:\/\/doi.org\/10.3181\/00379727-111-27849.","journal-title":"Exper Bio Med"},{"key":"221_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejphar.2013.08.033","volume":"718","author":"KPS Barbosa","year":"2013","unstructured":"Barbosa KPS, Santos LAM, Ribeiro EL, Fragoso IT, Rocha SWS, Nunes AKS, et al. Reduction of carrageenan-induced acute pulmonary inflammation in mice by novel thiazolidinedione derivative LPSF\/RA-4. Eur J Pharmacol. 2013;718:197\u2013205. https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.033.","journal-title":"Eur J Pharmacol"},{"key":"221_CR25","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. https:\/\/doi.org\/10.1038\/srep42717.","journal-title":"Sci Rep"},{"key":"221_CR26","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","journal-title":"J Med Chem"},{"key":"221_CR27","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/S0968-0896(03)00213-X","volume":"11","author":"N Bharti","year":"2003","unstructured":"Bharti N, Shailendra Sharma S, Naqvi F, Azam A. New palladium (II) complexes of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones: synthesis, spectral studies and in vitro anti-amoebic activity. Bioorg Med Chem. 2003;11:2923\u20139. https:\/\/doi.org\/10.1016\/S0968-0896(03)00213-X.","journal-title":"Bioorg Med Chem"},{"key":"221_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cbi.2018.01.016","volume":"283","author":"LMMG Silva","year":"2018","unstructured":"Silva LMMG, de Oliveira JF, Silva WL, da Silva AL, Almeida-Junior ASA, dos Santos VHB, et al. New 1,3-benzodioxole derivatives: synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis. Chem Biol Interact. 2018;283:20\u20139. https:\/\/doi.org\/10.1016\/j.cbi.2018.01.016.","journal-title":"Chem Biol Interact"},{"key":"221_CR29","doi-asserted-by":"publisher","first-page":"108899","DOI":"10.1016\/j.cbi.2019.108899","volume":"315","author":"PR Silva","year":"2020","unstructured":"Silva PR, de Oliveira JF, da Silva AL, Queiroz CM, Feitosa APS, Duarte DMFA, et al. Novel indol-3-yl-thiosemicarbazone derivatives: obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies. Chem Biol Interact. 2020;315:108899. https:\/\/doi.org\/10.1016\/j.cbi.2019.108899.","journal-title":"Chem Biol Interact"},{"key":"221_CR30","doi-asserted-by":"publisher","first-page":"111592","DOI":"10.1016\/j.ejmech.2019.111592","volume":"82","author":"AG Ribeiro","year":"2019","unstructured":"Ribeiro AG, Almeida SMV, Oliveira JF, Souza TRCL, Santos KL, Albuquerque APB, et al. Novel 4-quinoline-thiosemicarbazone derivatives: synthesis, antiproliferative activity, in vitro and in silico biomacromolecule interaction studies and topoisomerase inhibition. Eur J Med Chem. 2019;82:111592. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111592.","journal-title":"Eur J Med Chem"},{"key":"221_CR31","doi-asserted-by":"publisher","first-page":"111764","DOI":"10.1016\/j.ejmech.2019.111764","volume":"184","author":"Z He","year":"2019","unstructured":"He Z, Qiao H, Yang F, Zhou W, Gong Y, Zhang X, et al. Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent. Eur J Med Chem. 2019;184:111764. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111764.","journal-title":"Eur J Med Chem"},{"key":"221_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0300-483x(80)90110-9","volume":"16","author":"S Horv\u00e1th","year":"1980","unstructured":"Horv\u00e1th S. Cytotoxicity of drugs and diverse chemical agents to cell cultures. Toxicology. 1980;16:59\u201366. https:\/\/doi.org\/10.1016\/0300-483x(80)90110-9.","journal-title":"Toxicology"},{"key":"221_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejmech.2014.03.086","volume":"79","author":"F Vandresen","year":"2014","unstructured":"Vandresen F, Falzirolli H, Batista SAA, da Silva-Giardini APB, de Oliveira DN, Catharino RR, et al. Novel R-(\u00b1)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines. Eur J Med Chem. 2014;79:110\u20136. https:\/\/doi.org\/10.1016\/j.ejmech.2014.03.086.","journal-title":"Eur J Med Chem"},{"key":"221_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molstruc.2017.05.054","volume":"11455","author":"GR Subhashree","year":"2017","unstructured":"Subhashree GR, Haribabu J, Saranya S, Yuvaraj P, Krishnan DA, Karvembu R, et al. In vitro antioxidant, anti-inflammatory and in silico molecular docking studies of thiosemicarbazones. J Mol Struct. 2017;11455:160\u20139. https:\/\/doi.org\/10.1016\/j.molstruc.2017.05.054.","journal-title":"J Mol Struct"},{"key":"221_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxsci\/kfi176","volume":"86","author":"J Gao","year":"2005","unstructured":"Gao J, Lauer FT, Dunaway S, Burchiel SW. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol Sci. 2005;86:68\u201374. https:\/\/doi.org\/10.1093\/toxsci\/kfi176.","journal-title":"Toxicol Sci"},{"key":"221_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145\u201373. https:\/\/doi.org\/10.1146\/annurev.iy.07.040189.001045.","journal-title":"Annu Rev Immunol"},{"key":"221_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10875-005-4088-0","volume":"25","author":"X Cheng","year":"2005","unstructured":"Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, et al. Th1\/Th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol. 2005;25:246\u201353. https:\/\/doi.org\/10.1007\/s10875-005-4088-0.","journal-title":"J Clin Immunol"},{"key":"221_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cardiores.2006.08.009","volume":"73","author":"A Linde","year":"2007","unstructured":"Linde A, Mosier D, Blecha F, Melgarejo T. Innate immunity and inflammation\u2014new frontiers in comparative cardiovascular pathology. Cardiovasc Res. 2007;73:26\u201336. https:\/\/doi.org\/10.1016\/j.cardiores.2006.08.009.","journal-title":"Cardiovasc Res"},{"key":"221_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3181\/00379727-200-43426","volume":"200","author":"KJ Tracey","year":"1992","unstructured":"Tracey KJ, Cerami A. Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med. 1992;200:233\u20139. https:\/\/doi.org\/10.3181\/00379727-200-43426.","journal-title":"Proc Soc Exp Biol Med"},{"key":"221_CR40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","volume":"16","author":"R Giacomelli","year":"2017","unstructured":"Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, et al. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren\u2019s syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017;16:911\u201324. https:\/\/doi.org\/10.1016\/j.autrev.2017.07.012.","journal-title":"Autoimmun Rev"},{"key":"221_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2015.04.041","volume":"96","author":"MVO Cardoso","year":"2015","unstructured":"Cardoso MVO, Moreira DRM, Oliveira-Filho GB, Cavalcanti SMT, Coelho LCD, Esp\u00edndola JWP, et al. Design, synthesis and structure-activity relationship of phthalimides endowed with dual antiproliferative and immunomodulatory activities. Eur J Med Chem. 2015;96:491\u2013503. https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.041.","journal-title":"Eur J Med Chem"},{"key":"221_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","volume":"15","author":"JN Sharma","year":"2007","unstructured":"Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15:252\u20139. https:\/\/doi.org\/10.1007\/s10787-007-0013-x.","journal-title":"Inflammopharmacology"},{"key":"221_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","volume":"15","author":"J MacMicking","year":"1997","unstructured":"MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323\u201350. https:\/\/doi.org\/10.1146\/annurev.immunol.15.1.323.","journal-title":"Annu Rev Immunol"},{"key":"221_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1172\/JCI76210","volume":"125","author":"JT Walsh","year":"2015","unstructured":"Walsh JT, Hendrix S, Boato F, Smirnov I, Zheng J, Lukens JR, et al. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. J Clin Invest. 2015;125:699\u2013714. https:\/\/doi.org\/10.1172\/JCI76210.","journal-title":"J Clin Invest"},{"key":"221_CR45","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.chest.2017.05.019","volume":"152","author":"EH Bel","year":"2017","unstructured":"Bel EH, Brinke AT. New anti-eosinophil drugs for asthma and COPD: targeting the trait! Chest. 2017;152:1276\u201382. https:\/\/doi.org\/10.1016\/j.chest.2017.05.019.","journal-title":"Chest"},{"key":"221_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004;56:387\u2013437. https:\/\/doi.org\/10.1124\/pr.56.3.3.","journal-title":"Pharmacol Rev"},{"key":"221_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0165-6147(03)00077-4","volume":"24","author":"G Gaetano","year":"2003","unstructured":"Gaetano G, Donati MB, Cerletti C. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors. Trends Pharmacol Sci. 2003;24:245\u201352. https:\/\/doi.org\/10.1016\/S0165-6147(03)00077-4.","journal-title":"Trends Pharmacol Sci"},{"key":"221_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejmech.2014.12.039","volume":"92","author":"AM Alanazi","year":"2015","unstructured":"Alanazi AM, El-Azab AS, Al-Suwaidan IA, El-Tahir KEH, Asiri YA, Abdel-Aziz NI, et al. Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities. Eur J Med Chem. 2015;92:115\u201323. https:\/\/doi.org\/10.1016\/j.ejmech.2014.12.039.","journal-title":"Eur J Med Chem"},{"key":"221_CR49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0140-6736(08)60137-3","volume":"371","author":"TD Warner","year":"2008","unstructured":"Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet. 2008;371:270\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(08)60137-3.","journal-title":"Lancet"},{"key":"221_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejmech.2015.04.044","volume":"975","author":"P Singh","year":"2015","unstructured":"Singh P, Prasher P, Dhillon P, Bhatti R. Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: dual inhibition of 5-LOX and COX-2 enzymes. Eur J Med Chem. 2015;975:104\u201323. https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.044.","journal-title":"Eur J Med Chem"},{"key":"221_CR51","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.bmcl.2012.01.130","volume":"22","author":"J Kaur","year":"2012","unstructured":"Kaur J, Bhardwaj A, Huang Z, Knaus EE. N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation. Bioorg Med Chem Lett. 2012;22:2154\u20139. https:\/\/doi.org\/10.1016\/j.bmcl.2012.01.130.","journal-title":"Bioorg Med Chem Lett"},{"key":"221_CR52","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1016\/j.bmc.2012.09.013","volume":"20","author":"Y Bansal","year":"2012","unstructured":"Bansal Y, Silakari O. The therapeutic journey of benzimidazoles: a review. Bioorg Med Chem. 2012;20:6208\u201336. https:\/\/doi.org\/10.1016\/j.bmc.2012.09.013.","journal-title":"Bioorg Med Chem"},{"key":"221_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2478\/v10102-011-0031-9","volume":"4","author":"GA Asare","year":"2011","unstructured":"Asare GA, Addo P, Bugyei K, Gyan B, Adjei S, Otu-Nyarko LS, et al. Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri. Interdiscip Toxicol. 2011;4:206\u201310. https:\/\/doi.org\/10.2478\/v10102-011-0031-9.","journal-title":"Interdiscip Toxicol"},{"key":"221_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jiac.2015.08.004","volume":"21","author":"K Matsumoto","year":"2015","unstructured":"Matsumoto K, Obara S, Kuroda Y, Kizu J. Anti-inflammatory effects of linezolid on carrageenan-induced paw edema in rats. J Infect Chemother. 2015;21:889\u201391. https:\/\/doi.org\/10.1016\/j.jiac.2015.08.004.","journal-title":"J Infect Chemother"},{"key":"221_CR55","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/0006-2952(76)90062-9","volume":"25","author":"Y Oyanagui","year":"1976","unstructured":"Oyanagui Y. Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema. Biochem Pharmacol. 1976;25:1465\u201372. https:\/\/doi.org\/10.1016\/0006-2952(76)90062-9.","journal-title":"Biochem Pharmacol"},{"key":"221_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jep.2013.12.026","volume":"152","author":"X Niu","year":"2014","unstructured":"Niu X, Li Y, Li W, Hu H, Yao H, Li H. The anti-inflammatory effects of Caragana tangutica ethyl acetate extract. J Ethnopharmacol. 2014;152:99\u2013105. https:\/\/doi.org\/10.1016\/j.jep.2013.12.026.","journal-title":"J Ethnopharmacol"},{"key":"221_CR57","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3109\/13880209.2014.880487","volume":"52","author":"IO Ishola","year":"2014","unstructured":"Ishola IO, Agbaje EO, Adeyemi OO, Shukla R. Analgesic and anti-inflammatory effects of the methanol root extracts of some selected Nigerian medicinal plants. Pharm Biol. 2014;52:1208\u201316. https:\/\/doi.org\/10.3109\/13880209.2014.880487.","journal-title":"Pharm Biol"},{"key":"221_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejmech.2019.03.022","volume":"171","author":"Z Song","year":"2019","unstructured":"Song Z, Zhou Y, Zhang W, Zhan L, Yu Y, Chen Y, et al. Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury. Eur J Med Chem. 2019;171:54\u201365. https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.022.","journal-title":"Eur J Med Chem"},{"key":"221_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.intimp.2016.12.009","volume":"43","author":"TB Tumer","year":"2017","unstructured":"Tumer TB, Onder FC, Ipek H, Gungor T, Savranoglu S, Tok TT, et al. Biological evaluation and molecular docking studies of nitro benzamide derivatives with respect to in vitro anti-inflammatory activity. Int Immunopharmacol. 2017;43:129\u201339. https:\/\/doi.org\/10.1016\/j.intimp.2016.12.009.","journal-title":"Int Immunopharmacol"},{"key":"221_CR60","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1016\/j.bmcl.2013.08.061","volume":"23","author":"A G\u00f3mez-Rivera","year":"2013","unstructured":"G\u00f3mez-Rivera A, Aguilar-Mariscal H, Romero-Ceronio N, de la Fuente LFR, Lobato-Garc\u00eda CE. Synthesis and anti-inflammatory activity of three nitro chalcones. Bioorg Med Chem Lett. 2013;23:5519\u201322. https:\/\/doi.org\/10.1016\/j.bmcl.2013.08.061.","journal-title":"Bioorg Med Chem Lett"},{"key":"221_CR61","doi-asserted-by":"publisher","first-page":"105300","DOI":"10.1016\/j.ejps.2020.105300","volume":"148","author":"BC Roriz","year":"2020","unstructured":"Roriz BC, Buccini DF, dos Santos BF, Silva SRS, Domingues NLC, Moreno SE. Synthesis and biological activities of a nitro-shiff base compound as a potential anti-inflammatory agent. Eur J Pharm Sci. 2020;148:105300. https:\/\/doi.org\/10.1016\/j.ejps.2020.105300.","journal-title":"Eur J Pharm Sci"},{"key":"221_CR62","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.fct.2017.02.027","volume":"109","author":"LB Rodrigues","year":"2017","unstructured":"Rodrigues LB, Martins AOBPB, Ribeiro-Filho J, Ces\u00e1rio FRAS, Castro FF, de Albuquerque TR, et al. Anti-inflammatory activity of the essential oil obtained from Ocimum basilicum complexed with \u03b2-cyclodextrin (\u03b2-CD) in mice. Food Chem Toxicol. 2017;109:836\u201346. https:\/\/doi.org\/10.1016\/j.fct.2017.02.027.","journal-title":"Food Chem Toxicol"},{"key":"221_CR63","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/endo.138.6.5192","volume":"138","author":"H Tai","year":"1997","unstructured":"Tai H, Miyaura C, Pilbeam CC, Tamura T, Ohsugi Y, Koishihara Y, et al. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology. 1997;138:2372\u20139. https:\/\/doi.org\/10.1210\/endo.138.6.5192.","journal-title":"Endocrinology"},{"key":"221_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrep.2017.08.005","volume":"12","author":"A Basu","year":"2017","unstructured":"Basu A, Das AS, Sharma M, Pathak MP, Chattopadhyay P, Biswas K, Mukhopadhyay R. STAT3 and NF-\u03baB are common targets for kaempferol-mediated attenuation of COX-2 expression in IL-6-induced macrophages and carrageenan-induced mouse paw edema. Biochem Biophys Rep. 2017;12:54\u201361. https:\/\/doi.org\/10.1016\/j.bbrep.2017.08.005.","journal-title":"Biochem Biophys Rep"},{"key":"221_CR65","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bcp.2011.06.036","volume":"82","author":"S Hayashi","year":"2011","unstructured":"Hayashi S, Sumi Y, Ueno N, Murase A, Takada J. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure\u2013activity relationship. Biochem Pharmacol. 2011;82:755\u201368. https:\/\/doi.org\/10.1016\/j.bcp.2011.06.036.","journal-title":"Biochem Pharmacol"},{"key":"221_CR66","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejmech.2017.09.056","volume":"141","author":"SE Kassab","year":"2017","unstructured":"Kassab SE, Khedr MA, Ali HI, Abdalla MM. Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities. Eur J Med Chem. 2017;141:306\u201321. https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.056.","journal-title":"Eur J Med Chem"},{"key":"221_CR67","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejmech.2014.12.006","volume":"90","author":"D Newby","year":"2015","unstructured":"Newby D, Freitas AA, Ghafourian T. Decision trees to characterise the roles of permeability and solubility on the prediction of oral absorption. Eur J Med Chem. 2015;90:751\u201365. https:\/\/doi.org\/10.1016\/j.ejmech.2014.12.006.","journal-title":"Eur J Med Chem"},{"key":"221_CR68","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615\u201323. https:\/\/doi.org\/10.1021\/jm020017n.","journal-title":"J Med Chem"},{"key":"221_CR69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/oso\/9780199635733.003.0006","volume-title":"Epithelial cell culture: a practical approach","author":"P Artursson","year":"1996","unstructured":"Artursson P, Karlsson J, Ocklind G, Schipper N. Studying transport processes in absorptive epithelia. In: Shaw AJ, editor. Epithelial cell culture: a practical approach. Oxford: IRL Press at Oxford University; 1996. p. 111\u201333."},{"key":"221_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejmech.2018.03.067","volume":"151","author":"C Lambertucci","year":"2018","unstructured":"Lambertucci C, Marucci G, Ben DD, Buccioni M, Spinaci A, Kachler S, Klotz KN, Volpini R, et al. New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases. Eur J Med Chem. 2018;151:199\u2013213. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.067.","journal-title":"Eur J Med Chem"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00221-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-021-00221-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00221-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T08:26:11Z","timestamp":1724487971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-021-00221-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00221-7","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"19 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there were no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}